Acadia Pharmaceuticals | ACAD - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Acadia Pharmaceuticals USD 16.33M 28.24M 2026-09
ALKERMES USD 107.69M 35.17M 2026-09
Alnylam Pharmaceuticals USD 135.4M 27.38M 2026-09
Biogen USD 430.3M 26.4M 2026-09
BioMarin Pharmaceutical USD 946.11M 32.44M 2026-09
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Cara Therapeutics USD 4.62M 1.4M 2026-03
Corcept Therapeutics USD 21.92M 7.01M 2026-09
Cytokinetics USD 25.96M 5.45M 2026-09
Eisai JPY 87.53B 11.64B 2026-06
Eli Lilly USD 5.79B 319M 2026-09
Incyte USD 235.37M 1.16B 2026-09
J&J USD 9.32B 94M 2026-09
Moderna USD 259M 92M 2026-09
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Pfizer USD 4.07B 511M 2026-09
Prothena USD 1.69M 249K 2026-09
PTC Therapeutics USD 41.59M 1.14M 2026-09
Sarepta Therapeutics USD 45.7M 5.28M 2026-09
Ultragenyx Pharmaceutical USD 45M 6M 2026-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Vertex Pharmaceuticals USD 3.71B 99.2M 2026-09